NRX Pharmaceuticals Inc (NRXP) — Cash Flow Quality Index

Latest as of June 2020: -6.37x

NRX Pharmaceuticals Inc (NRXP) has a Cash Flow Quality Index of -6.37x as of June 2020. Operating cash flow of $-651.84K is below net income of $102.29K, suggesting accrual-heavy earnings not yet converted to cash. Explore NRX Pharmaceuticals Inc (NRXP) cash flow to debt to assess how comfortably operating cash covers total debt obligations.

Cash Flow Quality Index

-6.37x
Operating CF / Net Income

Operating Cash Flow

$-651.84K
USD

Net Income

$102.29K
USD

Data as of

Jun 2020
Most recent filing

NRX Pharmaceuticals Inc Cash Flow Quality Index (2018–2019)

Historical Cash Flow Quality Index for NRX Pharmaceuticals Inc across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see NRX Pharmaceuticals Inc operating cash flow efficiency.

Annual Cash Flow Quality Index for NRX Pharmaceuticals Inc (2018–2019)

Year-by-year earnings quality comparison for NRX Pharmaceuticals Inc.

Year Quality Index Operating CF (USD) Net Income YoY Change
2019 -1.94x $-792.73K $408.43K ▲ +72.9%
2018 -7.16x $-473.19K $66.10K
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.